Market Cap 351.68M
Revenue (ttm) 0.00
Net Income (ttm) -129.47M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 707,400
Avg Vol 722,014
Day's Range N/A - N/A
Shares Out 68.42M
Stochastic %K 93%
Beta 1.90
Analysts Strong Sell
Price Target $24.71

Company Profile

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; OPERA-01, the pivota...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 651 3316
Website: olema.com
Address:
780 Brannan Street, San Francisco, United States
Filvul
Filvul Jul. 31 at 3:29 PM
$OLMA give us 6$:)
0 · Reply
CerealDefense
CerealDefense Jul. 30 at 7:33 PM
$OLMA 🙄 just take all gains…sure, why not
0 · Reply
StardustTrader
StardustTrader Jul. 30 at 5:43 PM
$OLMA still the sweet spot for adds. But, not sure we will see them again
0 · Reply
justiceforb_85
justiceforb_85 Jul. 30 at 3:59 PM
$OLMA after moves with $CELC the data for palazestrant should be game-changing.
0 · Reply
CerealDefense
CerealDefense Jul. 30 at 3:34 AM
$OLMA can this finally stay over $5? Felt very undervalued at $3-4 especially looking at the company valuation.
0 · Reply
Filvul
Filvul Jul. 3 at 2:31 PM
0 · Reply
Winning_calls
Winning_calls Jun. 30 at 1:33 PM
$OLMA 😗😗
0 · Reply
Winning_calls
Winning_calls Jun. 30 at 3:51 AM
$OLMA pick me up @ $4.50
0 · Reply
4_4
4_4 Jun. 27 at 5:16 PM
$OLMA Buyout for Palazestrant would be nice. $NVS ? Probably jumping to conclusions before PFS info is out.
0 · Reply
justiceforb_85
justiceforb_85 Jun. 26 at 8:11 PM
$OLMA look forward to future updates of palazestrant.
0 · Reply
Latest News on OLMA
Olema Oncology to Participate in Upcoming Investor Conferences

May 21, 2025, 4:30 PM EDT - 2 months ago

Olema Oncology to Participate in Upcoming Investor Conferences


Olema Oncology Appoints Shawnte M. Mitchell, J.D.

Feb 18, 2025, 7:00 AM EST - 5 months ago

Olema Oncology Appoints Shawnte M. Mitchell, J.D.


Top 3 Health Care Stocks That May Explode In Q4

Dec 18, 2024, 7:46 AM EST - 8 months ago

Top 3 Health Care Stocks That May Explode In Q4

MODV SLN


Olema Pharmaceuticals: Advancing On Multiple Fronts

Nov 28, 2023, 11:52 AM EST - 1 year ago

Olema Pharmaceuticals: Advancing On Multiple Fronts


Olema: Two-Pronged Approach To Treat Breast Cancer Patients

Sep 18, 2023, 3:20 PM EDT - 2 years ago

Olema: Two-Pronged Approach To Treat Breast Cancer Patients


Olema Oncology: Best Contrarian Oncology Play For 2023

May 19, 2023, 4:30 PM EDT - 2 years ago

Olema Oncology: Best Contrarian Oncology Play For 2023


Filvul
Filvul Jul. 31 at 3:29 PM
$OLMA give us 6$:)
0 · Reply
CerealDefense
CerealDefense Jul. 30 at 7:33 PM
$OLMA 🙄 just take all gains…sure, why not
0 · Reply
StardustTrader
StardustTrader Jul. 30 at 5:43 PM
$OLMA still the sweet spot for adds. But, not sure we will see them again
0 · Reply
justiceforb_85
justiceforb_85 Jul. 30 at 3:59 PM
$OLMA after moves with $CELC the data for palazestrant should be game-changing.
0 · Reply
CerealDefense
CerealDefense Jul. 30 at 3:34 AM
$OLMA can this finally stay over $5? Felt very undervalued at $3-4 especially looking at the company valuation.
0 · Reply
Filvul
Filvul Jul. 3 at 2:31 PM
0 · Reply
Winning_calls
Winning_calls Jun. 30 at 1:33 PM
$OLMA 😗😗
0 · Reply
Winning_calls
Winning_calls Jun. 30 at 3:51 AM
$OLMA pick me up @ $4.50
0 · Reply
4_4
4_4 Jun. 27 at 5:16 PM
$OLMA Buyout for Palazestrant would be nice. $NVS ? Probably jumping to conclusions before PFS info is out.
0 · Reply
justiceforb_85
justiceforb_85 Jun. 26 at 8:11 PM
$OLMA look forward to future updates of palazestrant.
0 · Reply
StardustTrader
StardustTrader Jun. 17 at 9:41 PM
$OLMA adding a bit more
0 · Reply
JimCramerisadoofus
JimCramerisadoofus Jun. 12 at 1:36 PM
$OLMA Buy the dip!
0 · Reply
StardustTrader
StardustTrader Jun. 10 at 4:36 PM
$OLMA this is the zone. Averaging up a smidge.
0 · Reply
JimCramerisadoofus
JimCramerisadoofus Jun. 4 at 2:24 PM
$OLMA This company has no debt. Five analysts rate as BUY Three analysts rate as STRONG BUY 95% of shares are owned by institutions Strong pipeline of candidates to treat endocrine driven cancers. I’m in at $4.00
0 · Reply
djgestates
djgestates Jun. 4 at 11:21 AM
0 · Reply
Zeekola
Zeekola Jun. 3 at 8:37 PM
0 · Reply
valueinvestor1998
valueinvestor1998 Jun. 2 at 10:45 PM
$OLMA did they present poor data at ASCO?
4 · Reply
jgodski
jgodski Jun. 2 at 6:49 PM
$OLMA Any ideas why the selloff today other than some profit taking, maybe short selling to anticipate or drive a drop after recent news? I'm just in at $4.40.
0 · Reply
valueinvestor1998
valueinvestor1998 Jun. 2 at 4:13 AM
$OLMA should have picked it up at $3 😢
0 · Reply
spider521
spider521 May. 31 at 1:25 PM
$OLMA Analysts have set price targets range from a low of $18 to a high of $30, showing strong confidence in the company's future prospects.
0 · Reply
spider521
spider521 May. 31 at 1:24 PM
$OLMA Olema Pharmaceuticals will present at two major healthcare conferences in June 2025: Jefferies Global Healthcare Conference: June 4, 2025, at 11:40 a.m. ET in New York, in a fireside chat format. Goldman Sachs 46th Annual Global Healthcare Conference: June 11, 2025, at 8:00 a.m. ET in Miami, also as a fireside chat.
0 · Reply
StardustTrader
StardustTrader May. 28 at 5:12 PM
$OLMA very possibly reversing here. Will add if we retest 3s/ low 4s.
0 · Reply